Voglimust MF 1mg/500mg/0.3mg Tablet
Marketer
Prophex Health Care Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Voglimust MF 1mg/500mg/0.3mg Tablet
Diabexe Trio 1mg/500mg/0.3mg tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexe Trio should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to identify its symptoms—sweating, dizziness, headache, trembling—and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating women must consult their physician. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Voglimust MF 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglimust MF 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimust MF 1mg/500mg/0.3mg Tablet whole; do not damage it by chewing, crushing, or breaking. Administer on an empty stomach.
Common Side effects of Voglimust MF 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglimust MF 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimust MF 1mg/500mg/0.3mg Tablets should be administered on an empty stomach.
How Voglimust MF 1mg/500mg/0.3mg Tablet works:
Each Voglimust MF tablet (1mg/500mg/0.3mg) contains a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimust MF 1mg/500mg/0.3mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Voglimust MF 1mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Voglimust MF 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Voglimust MF 1mg/500mg/0.3mg tablets in individuals with kidney disease carries a high risk and is strongly discouraged. Medical advice should be sought before use. This medication is particularly unsuitable for those with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Voglimust MF 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. In individuals with mild to moderate hepatic dysfunction, Voglimust MF 1mg/500mg/0.3mg tablets are typically initiated at a reduced dosage; however, their use is contraindicated in those with severe liver disease.
What if you forget to take Voglimust MF 1mg/500mg/0.3mg Tablet :
Should you forget a dose of Voglimust MF 1mg/500mg/0.3mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimust MF 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently